| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |